Imagen de Portada

A Class of Computational Methods to Reduce Selection Bias when Designing Phase 3 Clinical Trials

Fuente: arXiv

Guardado en:

Detalles Bibliográficos
Autor principal:	Zhan, Tianyu
Formato:	Preprint
Publicado:	2023
Materias:	Methodology
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Semiparametric Weighted Spline Regression (SWSR) in Confirmatory Clinical Trials with Time-Varying Placebo Effects
por: Zhan, Tianyu, et al.
Publicado: (2025)

A Bayesian Treatment Selection Design for Phase II Randomised Cancer Clinical Trials
por: Komaki, Moka, et al.
Publicado: (2025)

An Adaptive Phase II Trial Design for Dose Selection and Addition in Microfilarial Infections
por: Zehetmayer, Sonja, et al.
Publicado: (2026)

An Integrated and Coherent Framework for Point Estimation and Hypothesis Testing with Concurrent Controls in Platform Trials
por: Zhan, Tianyu, et al.
Publicado: (2025)

A Comparative Evaluation of Bayesian Model-Assisted Two-Stage Designs for Phase I/II Clinical Trials
por: Sun, Hao, et al.
Publicado: (2025)

BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials
por: Chen, Yuxuan, et al.
Publicado: (2026)

Design of Bayesian Clinical Trials with Clustered Data
por: Hagar, Luke, et al.
Publicado: (2025)

The Win Ratio at the Design Stage of Clinical Trials
por: Kronthaler, David, et al.
Publicado: (2025)

Non-collapsibility and Built-in Selection Bias of Hazard Ratio in Randomized Controlled Trials
por: Bian, Helen, et al.
Publicado: (2024)

Negative Spillover: A Potential Source of Bias in Pragmatic Clinical Trials
por: Mann, Sean
Publicado: (2023)

Conditional Inference for Secondary Outcomes Based on the Testing Result for the Primary Outcome in Clinical Trials
por: Pan, Tianyu, et al.
Publicado: (2025)

Risk-inclusive Contextual Bandits for Early Phase Clinical Trials
por: Kanrar, Rohit, et al.
Publicado: (2025)

Selection Bias in Hybrid Randomized Controlled Trials using External Controls: A Simulation Study
por: Chiam, Han Chang, et al.
Publicado: (2025)

BMW: Bayesian Model-Assisted Adaptive Phase II Clinical Trial Design for Win Ratio Statistic
por: Zhu, Di, et al.
Publicado: (2026)

A general, flexible and harmonious framework to construct interpretable functions in regression analysis
por: Zhan, Tianyu, et al.
Publicado: (2025)

Adjusting for Selection Bias Due to Missing Eligibility Criteria in Emulated Target Trials
por: Benz, Luke, et al.
Publicado: (2024)

Assessing Omitted Variable Bias when the Controls are Endogenous
por: Diegert, Paul, et al.
Publicado: (2022)

A Two-Step Test to Identify Zero-Inflated Biomarkers in Early-Phase Clinical Trials
por: Xi, Nan Miles, et al.
Publicado: (2025)

Statistical Design of Pragmatic Trials Using Electronic Health Record Data when Outcome Assessments are Uncontrolled and Irregular
por: Bobb, Jennifer F., et al.
Publicado: (2026)

Priors for Reducing Asymptotic Bias of the Posterior Mean
por: Yoichi, Miyata, et al.
Publicado: (2024)

A Bayesian Approach for Selecting Relevant External Data (BASE): Application to a study of Long-Term Outcomes in a Hemophilia Gene Therapy Trial
por: Pan, Tianyu, et al.
Publicado: (2024)

Seamless Phase I--II Cancer Clinical Trials Using Kernel-Based Covariate Similarity
por: Makino, Kana, et al.
Publicado: (2025)

Incertus.jl -- The Julia Lego Blocks for Randomized Clinical Trial Designs
por: Ryeznik, Yevgen, et al.
Publicado: (2024)

A Workflow for Evaluating Regional Treatment Effect Heterogeneity in Multi-Regional Clinical Trials
por: Zhang, Cong, et al.
Publicado: (2026)

Toxicity Monitoring Rule for a Two-Cohort Phase II Clinical Trial with Bivariate Beta Prior
por: Wang, Yu, et al.
Publicado: (2026)

Priors from Envisioned Posterior Judgments: A Novel Elicitation Approach With Application to Bayesian Clinical Trials
por: Ouyang, Yongdong, et al.
Publicado: (2024)

Beyond Fixed Restriction Time: Adaptive Restricted Mean Survival Time Methods in Clinical Trials
por: Sun, Jinghao, et al.
Publicado: (2025)

Bias in mixed models when analysing longitudinal data subject to irregular observation: when should we worry about it and how can recommended visit intervals help in specifying joint models when needed?
por: Garrett, Rose, et al.
Publicado: (2024)

Bias-Reduced Estimation of Structural Equation Models
por: Jamil, Haziq, et al.
Publicado: (2025)

A Non-Parametric Sensitivity Analysis for Bounding Bias in Hybrid Control Trials
por: Gordon, Alissa, et al.
Publicado: (2025)

Biomarker-Guided Adaptive Enrichment Design with Threshold Detection for Clinical Trials with Time-to-Event Outcome
por: Hua, Kaiyuan, et al.
Publicado: (2024)

Deep Neural Networks Guided Ensemble Learning for Point Estimation
por: Zhan, Tianyu, et al.
Publicado: (2021)

Causal Covariate Selection for the Imputation-based Regression Calibration Method for Exposure Measurement Error Bias Correction
por: Tang, Wenze, et al.
Publicado: (2023)

A Bayesian Discrete Framework for Enhancing Decision-Making Processes in Clinical Trial Designs and Evaluations
por: Pramanik, Paramahansa, et al.
Publicado: (2026)

Reducing Symbiosis Bias Through Better A/B Tests of Recommendation Algorithms
por: Brennan, Jennifer, et al.
Publicado: (2023)

Some Bayesian Perspectives on Clinical Trials
por: Sokolova, Alexandra, et al.
Publicado: (2026)

Precision Dose-Finding Design for Phase I Oncology Trials by Integrating Pharmacology Data
por: Lee, Kyong Ju, et al.
Publicado: (2025)

TITE-STEIN: Time-to-event Simple Toxicity and Efficacy Interval Design to Accelerate Phase I/II Trials
por: Sun, Hao, et al.
Publicado: (2025)

Selective Information Borrowing for Region-Specific Treatment Effect Inference under Covariate Mismatch in Multi-Regional Clinical Trials
por: Li, Chenxi, et al.
Publicado: (2026)

Optimizing Feature Selection in Causal Inference: A Three-Stage Computational Framework for Unbiased Estimation
por: Yang, Tianyu, et al.
Publicado: (2025)